Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.
The distinction between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), two types of mature aggressive B-cell lymphomas that require distinct treatments, can be difficult because of forms showing features intermediate between DLBCL and BL (here called BL/DLBCL). They can be discrimi...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a759db1c2ae243f983e76502321cc628 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a759db1c2ae243f983e76502321cc628 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a759db1c2ae243f983e76502321cc6282021-11-04T06:08:59ZEpstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.1932-620310.1371/journal.pone.0024617https://doaj.org/article/a759db1c2ae243f983e76502321cc6282011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21931777/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The distinction between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), two types of mature aggressive B-cell lymphomas that require distinct treatments, can be difficult because of forms showing features intermediate between DLBCL and BL (here called BL/DLBCL). They can be discriminated by the presence of c-myc translocations characteristic of BL. However, these are not exclusive of BL and when present in DLBCL are associated with lower survival. In this study, we show that Epstein-Barr virus-induced gene 3 (EBI3) is differentially expressed among BL and DLBCL. Analysis of gene expression data from 502 cases of aggressive mature B-cell lymphomas available on Gene Expression Omnibus and immunohistochemical analysis of 184 cases of BL, BL/DLBCL or DLBCL, showed that EBI3 was not expressed in EBV-positive or -negative BL cases, whereas it was expressed by over 30% of tumoral cells in nearly 80% of DLBCL cases, independently of their subtypes. In addition, we show that c-myc overexpression represses EBI3 expression, and that DLBCL or BL/DLBCL cases with c-myc translocations have lower expression of EBI3. Thus, EBI3 immunohistochemistry could be useful to discriminate BL from DLBCL, and to identify cases of BL/DLBCL or DLBCL with potential c-myc translocations.Julie GoninFrédérique LarousserieChristian BastardJean-Michel PicquenotJérôme CouturierIsabelle Radford-WeissCéline DietrichNicole BrousseMarie-Cécile Vacher-LavenuOdile DevergnePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 9, p e24617 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Julie Gonin Frédérique Larousserie Christian Bastard Jean-Michel Picquenot Jérôme Couturier Isabelle Radford-Weiss Céline Dietrich Nicole Brousse Marie-Cécile Vacher-Lavenu Odile Devergne Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
description |
The distinction between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), two types of mature aggressive B-cell lymphomas that require distinct treatments, can be difficult because of forms showing features intermediate between DLBCL and BL (here called BL/DLBCL). They can be discriminated by the presence of c-myc translocations characteristic of BL. However, these are not exclusive of BL and when present in DLBCL are associated with lower survival. In this study, we show that Epstein-Barr virus-induced gene 3 (EBI3) is differentially expressed among BL and DLBCL. Analysis of gene expression data from 502 cases of aggressive mature B-cell lymphomas available on Gene Expression Omnibus and immunohistochemical analysis of 184 cases of BL, BL/DLBCL or DLBCL, showed that EBI3 was not expressed in EBV-positive or -negative BL cases, whereas it was expressed by over 30% of tumoral cells in nearly 80% of DLBCL cases, independently of their subtypes. In addition, we show that c-myc overexpression represses EBI3 expression, and that DLBCL or BL/DLBCL cases with c-myc translocations have lower expression of EBI3. Thus, EBI3 immunohistochemistry could be useful to discriminate BL from DLBCL, and to identify cases of BL/DLBCL or DLBCL with potential c-myc translocations. |
format |
article |
author |
Julie Gonin Frédérique Larousserie Christian Bastard Jean-Michel Picquenot Jérôme Couturier Isabelle Radford-Weiss Céline Dietrich Nicole Brousse Marie-Cécile Vacher-Lavenu Odile Devergne |
author_facet |
Julie Gonin Frédérique Larousserie Christian Bastard Jean-Michel Picquenot Jérôme Couturier Isabelle Radford-Weiss Céline Dietrich Nicole Brousse Marie-Cécile Vacher-Lavenu Odile Devergne |
author_sort |
Julie Gonin |
title |
Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
title_short |
Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
title_full |
Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
title_fullStr |
Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
title_full_unstemmed |
Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. |
title_sort |
epstein-barr virus-induced gene 3 (ebi3): a novel diagnosis marker in burkitt lymphoma and diffuse large b-cell lymphoma. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/a759db1c2ae243f983e76502321cc628 |
work_keys_str_mv |
AT juliegonin epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT frederiquelarousserie epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT christianbastard epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT jeanmichelpicquenot epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT jeromecouturier epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT isabelleradfordweiss epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT celinedietrich epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT nicolebrousse epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT mariececilevacherlavenu epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma AT odiledevergne epsteinbarrvirusinducedgene3ebi3anoveldiagnosismarkerinburkittlymphomaanddiffuselargebcelllymphoma |
_version_ |
1718445168274702336 |